(297) - First Experience With the Novel Proteasome Inhibitor Carfilzomib for Antibody Mediated Rejection After Lung Transplantation

Autor: Ensor, C.R., Zeevi, A., Morrell, M.R., Yousem, S.A., D’Cunha, J., Pilewski, J.M., Bermudez, C., Shullo, M.A., Teuteberg, J.J., McDyer, J.F.
Zdroj: In Journal of Heart and Lung Transplantation April 2014 33(4) Supplement:S114-S114
Databáze: ScienceDirect